Kevin McKernan
๐ค SpeakerAppearances Over Time
Podcast Appearances
Yeah, and the communication they gave to Joe was not very reassuring to Joe because they started saying there's no SV40 protein in there. And we never said there was protein. We said there's pieces of DNA in there that are worrisome that they can integrate, and you haven't done any genotoxicity studies.
Yeah, and the communication they gave to Joe was not very reassuring to Joe because they started saying there's no SV40 protein in there. And we never said there was protein. We said there's pieces of DNA in there that are worrisome that they can integrate, and you haven't done any genotoxicity studies.
Yeah, and the communication they gave to Joe was not very reassuring to Joe because they started saying there's no SV40 protein in there. And we never said there was protein. We said there's pieces of DNA in there that are worrisome that they can integrate, and you haven't done any genotoxicity studies.
Typically, when you have something like this, you've got to measure what's the insertional mutagenesis rate. And these vaccines got a hall pass because they redeemed mRNA. They're like, look, it's not DNA, so we don't need to do that, right? Right. But what they didn't tell you is that, yes, it's mRNA, but there's also DNA there.
Typically, when you have something like this, you've got to measure what's the insertional mutagenesis rate. And these vaccines got a hall pass because they redeemed mRNA. They're like, look, it's not DNA, so we don't need to do that, right? Right. But what they didn't tell you is that, yes, it's mRNA, but there's also DNA there.
Typically, when you have something like this, you've got to measure what's the insertional mutagenesis rate. And these vaccines got a hall pass because they redeemed mRNA. They're like, look, it's not DNA, so we don't need to do that, right? Right. But what they didn't tell you is that, yes, it's mRNA, but there's also DNA there.
In which case, if they were honest about how much DNA was there, they would have been forced to go through a genotoxicity study. And they would have had to look for insertional mutagenesis rates. That didn't occur on the mRNA vaccines. So that's part of the crux of the issue at hand.
In which case, if they were honest about how much DNA was there, they would have been forced to go through a genotoxicity study. And they would have had to look for insertional mutagenesis rates. That didn't occur on the mRNA vaccines. So that's part of the crux of the issue at hand.
In which case, if they were honest about how much DNA was there, they would have been forced to go through a genotoxicity study. And they would have had to look for insertional mutagenesis rates. That didn't occur on the mRNA vaccines. So that's part of the crux of the issue at hand.
And so now we're in the stage where we're scanning through tumors to look for integration events and looking for evidence of this in cancer biopsies. And we can find them now.
And so now we're in the stage where we're scanning through tumors to look for integration events and looking for evidence of this in cancer biopsies. And we can find them now.
And so now we're in the stage where we're scanning through tumors to look for integration events and looking for evidence of this in cancer biopsies. And we can find them now.
I'm working with a group in Germany. I was just presenting in Phoenix at a CHD conference down there. But this is what's been most concerning is in this most recent work, we were basically scanning tumors that had spike signals. So there's an immunohistochemistry you can run that's like an antibody that looks for the spike protein on tissue.
I'm working with a group in Germany. I was just presenting in Phoenix at a CHD conference down there. But this is what's been most concerning is in this most recent work, we were basically scanning tumors that had spike signals. So there's an immunohistochemistry you can run that's like an antibody that looks for the spike protein on tissue.
I'm working with a group in Germany. I was just presenting in Phoenix at a CHD conference down there. But this is what's been most concerning is in this most recent work, we were basically scanning tumors that had spike signals. So there's an immunohistochemistry you can run that's like an antibody that looks for the spike protein on tissue.
So the folks out there were scanning all the biopsies to see which ones had high spike. They found one that had really high spike, sent it to us for sequencing, and we can find components of Pfizer's vaccines inside this thing a year after vaccination. And what's even more- Inside the cancer tumor. It's in the tumor. So it's expressing spike. The plasmids are still there.
So the folks out there were scanning all the biopsies to see which ones had high spike. They found one that had really high spike, sent it to us for sequencing, and we can find components of Pfizer's vaccines inside this thing a year after vaccination. And what's even more- Inside the cancer tumor. It's in the tumor. So it's expressing spike. The plasmids are still there.
So the folks out there were scanning all the biopsies to see which ones had high spike. They found one that had really high spike, sent it to us for sequencing, and we can find components of Pfizer's vaccines inside this thing a year after vaccination. And what's even more- Inside the cancer tumor. It's in the tumor. So it's expressing spike. The plasmids are still there.
They're at about 100 copies per cell. They shouldn't be there a year later. They shouldn't be there at all. But the fact that they're a year later is remarkable. And the fact that they're at 100 copies per cell is even more astounding. That tells us that these things aren't going in and getting degraded. They're going in and they're replicating.
They're at about 100 copies per cell. They shouldn't be there a year later. They shouldn't be there at all. But the fact that they're a year later is remarkable. And the fact that they're at 100 copies per cell is even more astounding. That tells us that these things aren't going in and getting degraded. They're going in and they're replicating.